
Bridget E. Bunner
Examiner (ID: 19030, Phone: (571)272-0881 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1644, 1647 |
| Total Applications | 1463 |
| Issued Applications | 725 |
| Pending Applications | 157 |
| Abandoned Applications | 602 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6530067
[patent_doc_number] => 20100221217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'THERAPEUTIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/713497
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15026
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221217.pdf
[firstpage_image] =>[orig_patent_app_number] => 12713497
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/713497 | Therapeutic composition | Feb 25, 2010 | Issued |
Array
(
[id] => 9703930
[patent_doc_number] => 08828992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-09
[patent_title] => 'Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson\'s disease using the same'
[patent_app_type] => utility
[patent_app_number] => 13/202449
[patent_app_country] => US
[patent_app_date] => 2010-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29323
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202449
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202449 | Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson's disease using the same | Feb 24, 2010 | Issued |
Array
(
[id] => 7744400
[patent_doc_number] => 20120022046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections'
[patent_app_type] => utility
[patent_app_number] => 13/203351
[patent_app_country] => US
[patent_app_date] => 2010-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23959
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022046.pdf
[firstpage_image] =>[orig_patent_app_number] => 13203351
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/203351 | Thienopyridine derivatives for the treatment and prevention of dengue virus infections | Feb 23, 2010 | Issued |
Array
(
[id] => 6536886
[patent_doc_number] => 20100204214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/704460
[patent_app_country] => US
[patent_app_date] => 2010-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82087
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12704460
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/704460 | Histamine H3 inverse agonists and antagonists and methods of use thereof | Feb 10, 2010 | Issued |
Array
(
[id] => 6513841
[patent_doc_number] => 20100216699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'SEMI-SYNTHETIC GLYCOPEPTIDES HAVING ANTIBACTERIAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/697967
[patent_app_country] => US
[patent_app_date] => 2010-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24191
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216699.pdf
[firstpage_image] =>[orig_patent_app_number] => 12697967
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/697967 | SEMI-SYNTHETIC GLYCOPEPTIDES HAVING ANTIBACTERIAL ACTIVITY | Jan 31, 2010 | Abandoned |
Array
(
[id] => 7487774
[patent_doc_number] => 20110251215
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-10-13
[patent_title] => 'MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/692078
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71724
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0251/20110251215.pdf
[firstpage_image] =>[orig_patent_app_number] => 12692078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/692078 | Macrocyclic compounds and their use as kinase inhibitors | Jan 21, 2010 | Issued |
Array
(
[id] => 7487774
[patent_doc_number] => 20110251215
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-10-13
[patent_title] => 'MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/692078
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71724
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0251/20110251215.pdf
[firstpage_image] =>[orig_patent_app_number] => 12692078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/692078 | Macrocyclic compounds and their use as kinase inhibitors | Jan 21, 2010 | Issued |
Array
(
[id] => 4451308
[patent_doc_number] => 07964632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-21
[patent_title] => 'Methods of treatment using a prodrug of an excitatory amino acid'
[patent_app_type] => utility
[patent_app_number] => 12/688074
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48965
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/964/07964632.pdf
[firstpage_image] =>[orig_patent_app_number] => 12688074
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/688074 | Methods of treatment using a prodrug of an excitatory amino acid | Jan 14, 2010 | Issued |
Array
(
[id] => 9503569
[patent_doc_number] => 08741883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Compounds and methods for the diagnosis and treatment of amyloid associated diseases'
[patent_app_type] => utility
[patent_app_number] => 12/687070
[patent_app_country] => US
[patent_app_date] => 2010-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20970
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12687070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/687070 | Compounds and methods for the diagnosis and treatment of amyloid associated diseases | Jan 12, 2010 | Issued |
Array
(
[id] => 6590629
[patent_doc_number] => 20100130482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'DIAZABICYCLIC ARYL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 12/652512
[patent_app_country] => US
[patent_app_date] => 2010-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12311
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130482.pdf
[firstpage_image] =>[orig_patent_app_number] => 12652512
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/652512 | DIAZABICYCLIC ARYL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS | Jan 4, 2010 | Abandoned |
Array
(
[id] => 10635592
[patent_doc_number] => 09353082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-31
[patent_title] => 'Pharmaceutical compounds'
[patent_app_type] => utility
[patent_app_number] => 13/141205
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 120788
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141205
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141205 | Pharmaceutical compounds | Dec 22, 2009 | Issued |
Array
(
[id] => 6637232
[patent_doc_number] => 20100173847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'TFPI INHIBITORS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/643818
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 179
[patent_figures_cnt] => 179
[patent_no_of_words] => 27620
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173847.pdf
[firstpage_image] =>[orig_patent_app_number] => 12643818
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/643818 | TFPI inhibitors and methods of use | Dec 20, 2009 | Issued |
Array
(
[id] => 7501752
[patent_doc_number] => 20110263608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => '16-KETO ASPERGILLIMIDES AND HARMFUL ORGANISM CONTROL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 13/140625
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10651
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263608.pdf
[firstpage_image] =>[orig_patent_app_number] => 13140625
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140625 | 16-KETO ASPERGILLIMIDES AND HARMFUL ORGANISM CONTROL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT | Dec 20, 2009 | Abandoned |
Array
(
[id] => 6428159
[patent_doc_number] => 20100168359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'TRI-FUNCTIONAL UV-ABSORBING COMPOUNDS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/640019
[patent_app_country] => US
[patent_app_date] => 2009-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11948
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168359.pdf
[firstpage_image] =>[orig_patent_app_number] => 12640019
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/640019 | Tri-functional UV-absorbing compounds and use thereof | Dec 16, 2009 | Issued |
Array
(
[id] => 7488467
[patent_doc_number] => 20110251384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'CYCLIC CARBODIIMIDE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/139103
[patent_app_country] => US
[patent_app_date] => 2009-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13658
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251384.pdf
[firstpage_image] =>[orig_patent_app_number] => 13139103
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/139103 | Cyclic carbodiimide compounds | Dec 14, 2009 | Issued |
Array
(
[id] => 7501774
[patent_doc_number] => 20110263616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => '11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZA-TETRACYCLO[19.3.1.1(2,6).1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENE MALEATE SALT'
[patent_app_type] => utility
[patent_app_number] => 13/133288
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 6321
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263616.pdf
[firstpage_image] =>[orig_patent_app_number] => 13133288
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/133288 | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-maleate salt | Dec 8, 2009 | Issued |
Array
(
[id] => 7580889
[patent_doc_number] => 20110294772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'USE OF CYCLOSQUARAMIDE COMPOUNDS AS ANTI-TUMOUR AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/133939
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5305
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294772.pdf
[firstpage_image] =>[orig_patent_app_number] => 13133939
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/133939 | USE OF CYCLOSQUARAMIDE COMPOUNDS AS ANTI-TUMOUR AGENTS | Dec 8, 2009 | Abandoned |
Array
(
[id] => 7580948
[patent_doc_number] => 20110294831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => '11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZA-TETRACYCLO[19.3.1.1(2,6).1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENE CITRATE SALT'
[patent_app_type] => utility
[patent_app_number] => 13/133297
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 6474
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0294/20110294831.pdf
[firstpage_image] =>[orig_patent_app_number] => 13133297
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/133297 | 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt | Dec 8, 2009 | Issued |
Array
(
[id] => 8328698
[patent_doc_number] => 08236793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-07
[patent_title] => 'Diazabicyclic aryl derivatives as cholinergic receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 12/633505
[patent_app_country] => US
[patent_app_date] => 2009-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13359
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12633505
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/633505 | Diazabicyclic aryl derivatives as cholinergic receptor modulators | Dec 7, 2009 | Issued |
Array
(
[id] => 7670093
[patent_doc_number] => 20110319362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'STAT3 LIGANDS AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/128941
[patent_app_country] => US
[patent_app_date] => 2009-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20361
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128941
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128941 | STAT3 LIGANDS AND THERAPEUTIC USES THEREOF | Dec 6, 2009 | Abandoned |